225ac-psma-617
novartis
['225ac']
phase i dose-escalation results of psma targeted radionuclide therapy with alpha-radiolabeled antibody 225ac-j591 and beta-radioligand 177lu-psma i&amp;t. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology